Memantine Disrupts Motor Coordination through Anxiety-like Behavior in CD1 Mice

Memantine is an FDA approved drug for the treatment of Alzheimer’s disease. It reduces neurodegeneration in the hippocampus and cerebral cortex through the inhibition of extrasynaptic NMDA receptors in patients and mouse models. Potentially, it could prevent neurodegeneration in other brain areas an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuvaev, Anton N., Belozor, Olga S., Mozhei, Oleg I., Mileiko, Aleksandra G., Mosina, Ludmila D., Laletina, Irina V., Mikhailov, Ilia G., Fritsler, Yana V., Shuvaev, Andrey N., Teschemacher, Anja G., Kasparov, Sergey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027563/
https://www.ncbi.nlm.nih.gov/pubmed/35448027
http://dx.doi.org/10.3390/brainsci12040495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027563/
https://www.ncbi.nlm.nih.gov/pubmed/35448027
http://dx.doi.org/10.3390/brainsci12040495

Ejemplares similares